Asset Details
Do you wish to reserve the book?
Complement factor H–deficient mice develop spontaneous hepatic tumors
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Complement factor H–deficient mice develop spontaneous hepatic tumors
Do you wish to request the book?
Complement factor H–deficient mice develop spontaneous hepatic tumors
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Complement factor H–deficient mice develop spontaneous hepatic tumors
2020
Overview
Hepatocellular carcinoma (HCC) is difficult to detect, carries a poor prognosis, and is one of few cancers with an increasing yearly incidence. Molecular defects in complement factor H (CFH), a critical regulatory protein of the complement alternative pathway (AP), are typically associated with inflammatory diseases of the eye and kidney. Little is known regarding the role of CFH in controlling complement activation within the liver. While studying aging CFH-deficient (fH-/-) mice, we observed spontaneous hepatic tumor formation in more than 50% of aged fH-/- males. Examination of fH-/- livers (3-24 months) for evidence of complement-mediated inflammation revealed widespread deposition of complement-activation fragments throughout the sinusoids, elevated transaminase levels, increased hepatic CD8+ and F4/80+ cells, overexpression of hepatic mRNA associated with inflammatory signaling pathways, steatosis, and increased collagen deposition. Immunostaining of human HCC biopsies revealed extensive deposition of complement fragments within the tumors. Investigating the Cancer Genome Atlas also revealed that increased CFH mRNA expression is associated with improved survival in patients with HCC, whereas mutations are associated with worse survival. These results indicate that CFH is critical for controlling complement activation in the liver, and in its absence, AP activation leads to chronic inflammation and promotes hepatic carcinogenesis.
Publisher
American Society for Clinical Investigation
Subject
/ Aging
/ Animals
/ Biopsy
/ Carcinoma, Hepatocellular - genetics
/ Carcinoma, Hepatocellular - metabolism
/ Carcinoma, Hepatocellular - pathology
/ Collagen
/ Complement Factor H - deficiency
/ Complement Factor H - genetics
/ Complement Factor H - metabolism
/ Gene Expression Regulation, Neoplastic
/ Genomes
/ Glomerulonephritis, Membranoproliferative
/ Hereditary Complement Deficiency Diseases - genetics
/ Hereditary Complement Deficiency Diseases - metabolism
/ Hereditary Complement Deficiency Diseases - pathology
/ Humans
/ Kidney Diseases - metabolism
/ Kidneys
/ Liver
/ Liver Neoplasms - metabolism
/ Males
/ Mice
/ Mutation
/ Neoplasm Proteins - deficiency
/ Neoplasm Proteins - metabolism
/ Proteins
/ RNA
/ Tumors
